Hiemke, Christoph

A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model

Postina, R., Schroeder, A., Dewachter, I., Bohl, J., Schmitt, U., Kojro, E., Prinzen, C., Endres, K., Hiemke, C., Blessing, M., et al. (2004) · Journal of Clinical Investigation

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 638

Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment

Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology

Stress Responses and CortisolTreatment of Major Depression

Cited by 434

Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats

RYGULA, R., ABUMARIA, N., DOMENICI, E., HIEMKE, C., & FUCHS, E. (2006) · Behavioural Brain Research

Stress Responses and CortisolNeurotransmitter Receptor Influence on Behavior

Cited by 126

Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus

Araya-Callís, C., Hiemke, C., Abumaria, N., & Flugge, G. (2012) · Psychopharmacology

Treatment of Major DepressionStress Responses and Cortisol

Cited by 109

Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam

Rygula, R., Abumaria, N., Havemann-Reinecke, U., Rüther, E., Hiemke, C., Zernig, G., Fuchs, E., & Flügge, G. (2008) · Behavioural Pharmacology

Treatment of Major DepressionStress Responses and Cortisol

Cited by 109

Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats

Rygula, R., Abumaria, N., Flügge, G., Hiemke, C., Fuchs, E., Rüther, E., & Havemann-Reinecke, U. (2006) · Behavioural Pharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 104

Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine

Mann, K., Rossbach, W., Müller, M. J., Müller-Siecheneder, F., Pott, T., Linde, I., Dittmann, R. W., & Hiemke, C. (2006) · Psychoneuroendocrinology

Schizophrenia research and treatmentStress Responses and Cortisol

Cited by 78

Evaluation of naltrexone for dissociative symptoms in borderline personality disorder

Schmahl, C., Kleindienst, N., Limberger, M., Ludäscher, P., Mauchnik, J., Deibler, P., Brünen, S., Hiemke, C., Lieb, K., Herpertz, S., et al. (2012) · International Clinical Psychopharmacology

Personality Disorders and PsychopathologyPsychosomatic Disorders and Their Treatments

Cited by 63

A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting paliperidone

Schoretsanitis, G., Spina, E., Hiemke, C., & de Leon, J. (2018) · Expert Review of Clinical Pharmacology

Schizophrenia research and treatmentPharmacogenetics and Drug Metabolism

Cited by 50

Cerebrospinal Fluid Tau Protein Levels and 18F-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis of Alzheimer’s Disease

Yakushev, I., Bartenstein, P., Siessmeier, T., Hiemke, C., Scheurich, A., Lotz, J., Fellgiebel, A., & Müller, M. J. (2010) · Dementia and Geriatric Cognitive Disorders

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 9